The Safety of Radioiodine Therapy for Women of Reproductive Age
Radioiodine (131I) is an essential adjuvant treatment after thyroidectomy in patients with differentiated thyroid carcinoma as well as Graves’ disease (hyperthyroidism). Generally 131I is safe, It has some side effects. Infertility is one an important issues for patients who will consider to receiv...
Saved in:
| Published in: | Journal of Midwifery (Online) Vol. 4; no. 1; pp. 1 - 6 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
Faculty of Medicine, Universitas Andalas
18-09-2019
|
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Radioiodine (131I) is an essential adjuvant treatment after thyroidectomy in patients with differentiated thyroid carcinoma as well as Graves’ disease (hyperthyroidism). Generally 131I is safe, It has some side effects. Infertility is one an important issues for patients who will consider to receive the therapy, especially for woman in reproductive age. This is reviewed in this paper. Studies reported, in hyperthyroidism and thyroid cancer patients who received 131I therapy, demonstrated no significant radiation effect, some of patients may have experienced short-term reproductive organs disfunction and changes generally resolve. There is no effect of 131I to subsequent pregnancy documented. |
|---|---|
| ISSN: | 2598-3180 2598-3180 |
| DOI: | 10.25077/jom.4.1.1-6.2019 |